Shareholder alert: ademi llp investigates whether alimera sciences, inc. has obtained a fair price for its public shareholders

Milwaukee , june 24, 2024 /prnewswire/ -- ademi llp is investigating alimera (nasdaq: alim) for possible breaches of fiduciary duty and other violations of law in its transaction with ani pharmaceuticals. click here to learn how to join the https://www.ademilaw.com/case/alimera-sciences-inc or call guri ademi toll-free at 866-264-3995.
ALIM Ratings Summary
ALIM Quant Ranking